Intravitreal vascular endothelial growth factor (VEGF) inhibitor injection in unrecognised early pregnancy

Summary The use of intravitreal vascular endothelial growth factor (VEGF) inhibitor medications has widened considerably to include indications affecting females of reproductive age. Our patient was inadvertently exposed to bevacizumab within the first trimester when placental growth and fetal organ...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Investigational new drugs 2016-10, Vol.34 (5), p.650-653
Hauptverfasser:	Kianersi, Farzan, Ghanbari, Heshmatollah, Naderi Beni, Zahra, Naderi Beni, Afsaneh
Format:	Artikel
Sprache:	eng
Schlagworte:	Abortion, Spontaneous Adult Angiogenesis Inhibitors - therapeutic use Bevacizumab Bevacizumab - therapeutic use Diabetes Mellitus, Type 1 - drug therapy Diabetic Retinopathy - drug therapy Female Fetuses Growth factors Humans Inhibitors Intravitreal Injections Medicine Medicine & Public Health Oncology Organogenesis Pharmacology/Toxicology Pregnancy Pregnancy Trimester, First Short Report Vascular endothelial growth factor Vascular Endothelial Growth Factor A - antagonists & inhibitors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!